Navigation Links
North Shore-LIJ's Feinstein Institute Hosts Academic Commencement and Convocation
Date:5/28/2013

Manhasset, NY (PRWEB) May 28, 2013

The 2013 Commencement Exercises for the Elmezzi Graduate School of Molecular Medicine and the Academic Convocation for the Hofstra North Shore-LIJ School of Medicine were held May 23 at The Feinstein Institute for Medical Research. Each year during this event, the Elmezzi Graduate School awards an honorary degree to an outstanding physician who has advanced biomedical research and improved medical treatment for patients. This year, Frederick W. Alt, PhD, from Harvard Medical School and Boston Children's Hospital, was recognized for his work in cancer and immunology.

During the commencement exercises for the Elmezzi Graduate School, students who have completed their dissertation studies are granted the degree of Doctor of Philosophy, Molecular Medicine. The Elmezzi Graduate School of Molecular Medicine is a PhD program for physicians who wish to pursue careers in biomedical education. During their training, Elmezzi students conduct research in Feinstein Institute laboratories to advance biomedical knowledge and to pursue new therapeutic approaches and diagnostic tools. This year, three graduate students received their degrees:

  •     Eitan Giat, MD, for his work in lupus. His thesis is entitled “The Inhibition of the Interferon Signature by the Dweus Peptide through Inactivation of HMGB1.”
  •     Ben Lu, MD, for his work in inflammation. His thesis is entitled “The Regulation of HMGB1 Release.”
  •     Sergio I. Valdes-Ferrer, MD, for his work in sepsis. His thesis is entitled “HMGB1 is a Key Mediator of Sustained Inflammation in Sepsis Survivors.”

The academic convocation for the Hofstra North Shore-LIJ School of Medicine acknowledged all current professorships and presented the new School of Medicine professors. Those who received honorary professorships include:

  •     Veronica M. Catanese, MD, MBA, vice dean/dean for Academic Affairs of Hofstra North Shore-LIJ School of Medicine, received the Dr. Leo A. Guthart Endowed Chair.
  •     Betty Diamond, MD, head of the Center for Autoimmune and Musculoskeletal Diseases at the Feinstein Institute, received the Maureen and Ralph Nappi Professor of Autoimmune Diseases at The Feinstein Institute for Medical Research.
  •     Samuel Packer, MD, professor of Ophthalmology at the Hofstra North Shore-LIJ School of Medicine, received the Florence and Robert Kaufman Professor of Medical Ethics.
  •     Charles Schleien, MD, professor of Pediatrics at the Hofstra North Shore-LIJ School of Medicine, received the Philip Lanzkowsky, MD Professor of Pediatrics.

In addition, Frederick W. Alt, PhD, was presented with an honorary degree: Candidate for Degree of Doctor of Science honoris causa. Dr. Alt is the Charles A. Janeway Professor of Pediatrics in the Department of Pediatrics at Harvard Medical School, a professor in the Department of Genetics at Harvard Medical School, and an investigator in the Howard Hughes Medical Institute at Boston Children's Hospital. Throughout his career, Dr. Alt has studied cellular mechanisms that generate and suppress genome instability associated with cancer and the mechanisms employed by the immune system to generate diverse antibody repertoires. His current work continues to focus on areas where the fields of cancer biology and immunology intersect.

About The Elmezzi Graduate School of Molecular Medicine

Located in Manhasset, NY, The Elmezzi Graduate School of Molecular Medicine is part of the North Shore-LIJ Health System and in partnership with The Feinstein Institute for Medical Research. The Elmezzi Graduate School of Molecular Medicine was established in 1994 and is a PhD program for physicians who wish to pursue careers in biomedical research. The program is an individually tailored program with a strong emphasis on translational research. For more information, visit http://www.ElmezziGraduateSchool.org.

About The Feinstein Institute for Medical Research

Headquartered in Manhasset, NY, The Feinstein Institute for Medical Research is home to international scientific leaders in many areas including Parkinson's disease, Alzheimer’s disease, psychiatric disorders, rheumatoid arthritis, lupus, sepsis, human genetics, pulmonary hypertension, leukemia, neuroimmunology, and medicinal chemistry. The Feinstein Institute, part of the North Shore-LIJ Health System, ranks in the top 5th percentile of all National Institutes of Health grants awarded to research centers. For more information, visit http://www.FeinsteinInstitute.org.

Read the full story at http://www.prweb.com/releases/2013/5/prweb10775139.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. New online portal, app provide information on tsunami zones in the Northwest
2. A North American first at the Montreal Heart Institute
3. Symtrex Inc. Signs Up with ImmuneSecurity to Launch LogInspect to the North American Market
4. Northwestern launches comprehensive program for patients with bicuspid aortic valve disease
5. Northwestern Medicine hosts the National Marfan Foundations Annual Conference
6. Northwestern researchers investigate treatment for tumor cells in spinal fluid
7. North Texas Cities to Start West Nile Spraying Thursday
8. Northeasterns Barnett Institute announces formation of leading analytics company, BioAnalytix, LLC
9. Power Slowly Returns to Much of Northeast After Sandy
10. Kessler awarded $2 million federal grant for Northern NJ Traumatic Brain Injury System
11. Heart Health Worst in the South, Best in Northeast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... , ... April 25, 2017 , ... A stressful work ... work can also decrease overall productivity and performance in the workplace. The goal of ... During the last few weeks of April, Clearview Resolution Services will be shutting down ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... modern procedure that achieves results in a fraction of the time as traditional ... NV, with Significance Dental Specialists, now offers this revolutionary treatment with or without ...
(Date:4/25/2017)... ... , ... Saad B. Chaudhary, MD is committed to providing the highest quality of spine care ... on preventative care with all my patients to alleviate possible future issues. I am pleased ... contact my office and my trained staff will assist you in any way possible.” , ...
(Date:4/25/2017)... ... April 25, 2017 , ... Amendia, Inc., ... of its strategic partnership with and platinum sponsorship of Global Spine Outreach (“GSO”), ... and effective management of complex spine deformity cases, particularly in children. , GSO’s ...
(Date:4/24/2017)... Lake City, UT (PRWEB) , ... April 24, 2017 , ... ... their efforts to encourage sustainability, innovate new strategies to reduce waste, and support renewable ... herbal remedy provider. They look to nature to find solutions for health issues, and ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... Research and Markets has announced the addition ... Addressing Production Complexities Through Risk Management and Quality by ... ... Market Prospects: Overcoming Production Complexities Through Risk Management and ... current trends in the global biosimilars market, with a ...
(Date:4/20/2017)... , April 20, 2017  AbbVie (NYSE: ABBV), ... percent (n=145/146) of chronic hepatitis C virus (HCV) ... or 6 and compensated cirrhosis (Child-Pugh A) achieved ... 12 ) with its investigational, pan-genotypic regimen of ... were seen following 12 weeks of G/P treatment ...
(Date:4/19/2017)... CRH) (NYSE MKT: CRHM) (the "Company"), announces that it will participate ... the Sheraton Hotel in Toronto, Ontario . ... is scheduled to present on Tuesday, May 2 at 10:00 am. ... the Board, Tony Holler will also attend the event. ... For more details about the ...
Breaking Medicine Technology: